FDA Propels Insulin Affordability with Semglee

This content originally appeared on diaTribe. Republished with permission. By Karena Yan, Joseph Bell, and Arvind Sommi Semglee may provide a cheaper alternative to Lantus (insulin glargine) – it costs $148 for five pre-filled insulin pens. Semglee, which was approved last year as a new basal insulin for adults and children with type 1 diabetes […]

Semglee, A Low-Cost Basal Insulin, Comes to the US

This content originally appeared on diaTribe. Republished with permission. By Karena Yan and Joseph Bell A more affordable alternative to Lantus (insulin glargine) will cost $148 for five pre-filled insulin pens Mylan and Biocon Biologics announced last month the long-awaited US launch of Semglee, a new insulin aiming to be deemed “biosimilar” to insulin glargine (basal insulin) […]